Project Grant R01DK141570
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $728,801 Project Grant to the Regents of the University of Michigan under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a 5-year project to test a novel weight navigation program aimed at overcoming barriers to obesity treatment in primary care settings. The project seeks to improve utilization of effective...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $3,145,056 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Duke University. The project aims to collect real-world evidence on the use of anti-obesity medications (AOMs) in adolescents, examining the reach, effectiveness, and potential unintended consequences of these treatments within clinical settings. The 4-year project will recruit a cohort of...
- This $695,295 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which administers the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded on March 15, 2025 to the Research Foundation for the State University of New York (RF SUNY) to support a research project titled "Developmental Trajectories of Reinforcer Pathology and Childhood Obesity". The project aims to...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This $1,021,719.00 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant recipient, Emmyon, Inc., is developing a novel small molecule therapeutic (EMMY1-25) that has demonstrated the ability to promote weight loss without muscle loss and protect against dysfunction of pancreatic beta cells in mouse models of obesity and type 2...
- This $854,803 federal Project Grant was awarded on June 13, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund the creation of a comprehensive, curated data repository for indirect calorimetry experiments in mice, which will capture critical data on factors influencing energy homeostasis, such as food intake, metabolic rate, and physical activity....
- This $224,088 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to investigate the physiological regulation of energy intake at meals following weight loss. The research will leverage data from two ongoing NIDDK-funded studies - the ARROW study, which examines predictors of long-term weight loss maintenance, and the...
- This federal Project Grant award in the amount of $1,428,186.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Massachusetts. The project aims to investigate the role of CYP4F enzymes in regulating N-acyl amino acid signaling in humans, which has implications for understanding the early...
This $942,000 federal project grant was awarded on September 16, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a feasibility project at Rush University Medical Center to develop a primary care-based weight management treatment program for individuals discontinuing anti-obesity medications (AOMs). The goal is to quickly identify patients who discontinue AOMs and enroll them in a tailored behavioral program to enhance long-term weight management and health benefits. The program will focus on reducing food cue reactivity, which is a key concern for those discontinuing AOMs. This feasibility project leverages the electronic health record and a self-reporting method to track AOM use and discontinuation in primary care patients, forming the foundation for the behavioral weight management program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $942.0k | 9/15/25 |